On July 2, Shougang LanzaTech fell 15.29% in regular trading, trading at HK$43.98/share, with turnover of HK$23.03 million.
On the news front, the company announced that the global offering price stabilization period ended on June 28. The overall coordinator did not exercise the over-allotment option, and the stabilization price operator Yuexi Securities conducted no stabilization actions during the entire period. With the stabilization mechanism now expired, the stock has lost its potential price support floor.
Since its listing on June 3 at an IPO price of HK$14.60, the stock had accumulated substantial gains, with the share price once surging above HK$54 — representing a peak gain of over 270%. The expiration of the stabilization period triggered concentrated profit-taking among short-term holders, significantly amplifying selling pressure. The company is the world's largest enterprise utilizing synthetic biology technology in the CCUS industry, with four operational production facilities across China and a combined annual ethanol capacity of 210,000 tonnes.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments